Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Walker

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker
Optics Express|May 23, 2009
C-band polarisation orthogonality preservation in 5Gb/s, 50microm multimode fibre links up to 3kmEtienne Rochat, Stuart Walker, Michael Parker
Therapeutic Innovation & Regulatory Science|February 8, 2020
Patients' Perspectives of the Pharmaceutical Regulatory and Reimbursement Systems in Istanbul, TurkeyEmel Mashaki Ceyhan, Stuart Walker, Sam Salek
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient PerspectiveBennett Levitan, Lawrence D Phillips, Stuart Walker
Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory AuthoritiesNeil McAuslane, James Leong, Lawrence Liberti, et al.
Rapid Communications in Mass Spectrometry : RCM|May 29, 2003
Identification of diastereomeric chlorophyll allomers by atmospheric pressure chemical ionisation liquid chromatography/tandem mass spectrometryJ Stuart Walker, Chi Jie, Brendan J Keely
Therapeutic Innovation & Regulatory Science|January 2, 2021
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and OpportunitiesTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Frontiers in Pharmacology|January 9, 2019
The South African Regulatory System: Past, Present, and FutureAndrea Keyter, Shabir Banoo, Sam Salek, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2013
Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectivesJames Leong, Neil McAuslane, Stuart Walker, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker
Optics Express|May 23, 2009
C-band polarisation orthogonality preservation in 5Gb/s, 50microm multimode fibre links up to 3kmEtienne Rochat, Stuart Walker, Michael Parker
Therapeutic Innovation & Regulatory Science|February 8, 2020
Patients' Perspectives of the Pharmaceutical Regulatory and Reimbursement Systems in Istanbul, TurkeyEmel Mashaki Ceyhan, Stuart Walker, Sam Salek
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient PerspectiveBennett Levitan, Lawrence D Phillips, Stuart Walker
Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory AuthoritiesNeil McAuslane, James Leong, Lawrence Liberti, et al.
Rapid Communications in Mass Spectrometry : RCM|May 29, 2003
Identification of diastereomeric chlorophyll allomers by atmospheric pressure chemical ionisation liquid chromatography/tandem mass spectrometryJ Stuart Walker, Chi Jie, Brendan J Keely
Therapeutic Innovation & Regulatory Science|January 2, 2021
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and OpportunitiesTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Frontiers in Pharmacology|January 9, 2019
The South African Regulatory System: Past, Present, and FutureAndrea Keyter, Shabir Banoo, Sam Salek, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2013
Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectivesJames Leong, Neil McAuslane, Stuart Walker, et al.
Pageof 10